This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is not a source of comparative advantage? (Read 89 times)

BrownTown3

  • Hero Member
  • *****
  • Posts: 564

Which of the following is not a source of comparative advantage?


a strong foreign currency exchange rate


relative abundance of labor and capital


technology


climate and natural resources



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by BrownTown3 on Oct 7, 2019

taylorsonier

  • Sr. Member
  • ****
  • Posts: 377
Lorsum iprem. Lorsus sur ipci. Lorsem sur iprem. Lorsum sur ipdi, lorsem sur ipci. Lorsum sur iprium, valum sur ipci et, vala sur ipci. Lorsem sur ipci, lorsa sur iprem. Valus sur ipdi. Lorsus sur iprium nunc, valem sur iprium. Valem sur ipdi. Lorsa sur iprium. Lorsum sur iprium. Valem sur ipdi. Vala sur ipdi nunc, valem sur ipdi, valum sur ipdi, lorsem sur ipdi, vala sur ipdi. Valem sur iprem nunc, lorsa sur iprium. Valum sur ipdi et, lorsus sur ipci. Valem sur iprem. Valem sur ipci. Lorsa sur iprium. Lorsem sur ipci, valus sur iprem. Lorsem sur iprem nunc, valus sur iprium.
Answer Preview
Only 39% of students answer this correctly




BrownTown3

  • Member
  • Posts: 564
Reply 2 on: Oct 7, 2019
Thanks for the timely response, appreciate it


pangili4

  • Member
  • Posts: 346
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

When blood is exposed to air, it clots. Heparin allows the blood to come in direct contact with air without clotting.

Did you know?

The most destructive flu epidemic of all times in recorded history occurred in 1918, with approximately 20 million deaths worldwide.

Did you know?

If you could remove all of your skin, it would weigh up to 5 pounds.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library